Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
An engineered trivalent Fc drug candidate is a potent inhibitor of FcγR-driven immune cell activation and autoimmune diseases in animal models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947
Self-citationAnti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
Self-citationRecapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc
Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N., Paulson, J. C., & Ravetch, J. V. (2008) · Science · doi:10.1126/science.1154315 · Cited by 849
Self-citationInfusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura
Debré, M., Griscelli, C., Bonnet, M.-C., Carosella, E., Philippe, N., Reinert, P., Vilmer, E., Kaplan, C., Fridman, W. H., & Teillaud, J.-L. (1993) · The Lancet · doi:10.1016/0140-6736(93)92000-j · Cited by 329
Internalization and degradation of macrophage Fc receptors bound to polyvalent immune complexes.
Mellman, I., & Plutner, H. (1984) · The Journal of cell biology · doi:10.1083/jcb.98.4.1170 · Cited by 251
Washburn, N., Schwab, I., Ortiz, D., Bhatnagar, N., Lansing, J. C., Medeiros, A., Tyler, S., Mekala, D., Cochran, E., Sarvaiya, H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422481112 · Cited by 225
Self-citationLiao, F., Shin, H. S., & Rhee, S. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3659 · Cited by 144
Developing the IVIG biomimetic, Hexa-Fc, for drug and vaccine applications
Czajkowsky, D. M., Andersen, J. T., Fuchs, A., Wilson, T. J., Mekhaiel, D., Colonna, M., He, J., Shao, Z., Mitchell, D. A., Wu, G., et al. (2015) · Scientific Reports · doi:10.1038/srep09526 · Cited by 38
Cited by
Antibody Structure and Function: The Basis for Engineering Therapeutics
Chiu, M. L., Goulet, D. R., Teplyakov, A., & Gilliland, G. L. (2019) · Antibodies · doi:10.3390/antib8040055 · Cited by 638
Tackling COVID-19 with neutralizing monoclonal antibodies
Corti, D., Purcell, L. A., Snell, G., & Veesler, D. (2021) · Cell · doi:10.1016/j.cell.2021.05.005 · Cited by 383
Considerations for the Design of Antibody-Based Therapeutics
Goulet, D. R., & Atkins, W. M. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.05.031 · Cited by 302
Delidakis, G., Kim, J. E., George, K., & Georgiou, G. (2022) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-082721-024500 · Cited by 87
Tackling COVID-19 with neutralizing monoclonal antibodies
Corti, D., Purcell, L. A., Snell, G., & Veesler, D. (2021) · Cell · doi:10.1016/j.cell.2021.07.027 · Cited by 78
“Whether occupancy is relevant to viral neutralization is unclear, but it might affect the ability of mAbs to trigger effector functions, since the density of mAbs on virions or infected cells can influence the ability to engage and activate low-affinity Fcg-receptors (Ortiz et al., 2016).”
Metadata
- Authors
- Ortiz, D. F., Lansing, J. C., Rutitzky, L., Kurtagic, E., Prod’homme, T., Choudhury, A., Washburn, N., Bhatnagar, N., Beneduce, C., Holte, K., Prenovitz, R., Child, M., Killough, J., Tyler, S., Brown, J., Nguyen, S., Schwab, I., Hains, M., Meccariello, R., Markowitz, L., Wang, J., Zouaoui, R., Simpson, A., Schultes, B., Capila, I., Ling, L., Nimmerjahn, F., Manning, A. M., & Bosques, C. J.
- Venue
- Science Translational Medicine
- Published
- 2016-11-16
- Volume
- 8
- Issue
- 365
- Pages
- 365ra158-365ra158
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2549947203
- Cited by
- 67
- References
- 8
- FWCI
- 7.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors. https://app.cochat.ai/papers/10.1126/scitranslmed.aaf9418
- The paper
- Ortiz, D. F., Lansing, J. C., Rutitzky, L., Kurtagic, E., Prod’homme, T., Choudhury, A., Washburn, N., Bhatnagar, N., Beneduce, C., Holte, K., Prenovitz, R., Child, M., Killough, J., Tyler, S., Brown, J., Nguyen, S., Schwab, I., Hains, M., Meccariello, R., . . . Bosques, C. J. (2016). Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aaf9418
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.